Sulcová J, Macek M, Chudoba D, Hubl W, Hill M, Stárka L
Department of Steroid Hormones, Institute of Endocrinology, Prague, Czech Repbulic.
J Steroid Biochem Mol Biol. 1994 Dec;51(5-6):315-8. doi: 10.1016/0960-0760(94)90045-0.
The results of measurement of 17-hydroxyprogesterone (17-OH-P) in 125 samples of amniotic fluid (AF) from early amniocenteses are presented. The fetuses from all pregnancies studied were unaffected by congenital adrenal hyperphasia caused by 21-hydroxylase deficiency. The AF 17-OH-P level increases slightly but significantly between the 11th and 15th week of gestation, with a maximum in the 14th week. There is no difference between the values measured in male and female fetuses. The AF 17-OH-P levels from the early gestation were compared with those from the 16th-22nd week of pregnancy (published previously). The overall differences of AF 17-OH-P concentrations when considered in all gestational age groups in the whole period 12-22 weeks were statistically insignificant. Thus, the biochemical prenatal diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency and control of its early fetal treatment could be carried out starting from the end of the first trimester in the same way as at the later period of gestation.
本文展示了对125例早期羊膜穿刺术获取的羊水样本中17-羟孕酮(17-OH-P)的测量结果。所有研究妊娠中的胎儿均未受21-羟化酶缺乏所致先天性肾上腺皮质增生的影响。妊娠11周至15周期间,羊水17-OH-P水平略有升高但差异显著,在第14周达到最高值。男胎和女胎的测量值之间无差异。将妊娠早期的羊水17-OH-P水平与妊娠第16 - 22周(先前已发表)的水平进行比较。在整个12 - 22周妊娠期间的所有孕周组中,羊水17-OH-P浓度的总体差异无统计学意义。因此,对于21-羟化酶缺乏所致先天性肾上腺皮质增生的生化产前诊断及其早期胎儿治疗的监测,可从孕早期末开始,与妊娠后期采用相同的方式进行。